Gilead to acquire Tubulis to expand ADC oncology capabilities

FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Alloy Therapeutics and Biogen expand partnership with multi-target antisense collaboration

Sanofi reports positive phase 2 results for lunsekimig in asthma and CRSwNP

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products

Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Parnell launches first FDA-approved generic florfenicol and flunixin combination for bovine respiratory disease

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management

ALK secures EU approval for EURneffy 1 mg as needle-free adrenaline option for children

Delonix Bioworks launches Phase 1 trial of next-generation MenB OMV vaccine DX-104